SGLT2 抑制剂通过抑制 CD8 + T 细胞活化来促进酮体生成，从而改善 MASH
https://www.cell.com/cell-metabolism/abstract/S1550-4131(24)00332-2
肠道菌群与人类 NAFLD：从代谢紊乱中解开微生物特征
https://wellesu.com/10.1038/s41575-020-0269-9
https://www.nature.com/articles/s41575-020-0269-9
肠道菌群可预测无糖尿病的 MASLD 患者对恩格列净的治疗反应
https://onlinelibrary.wiley.com/doi/full/10.1111/liv.70023
source
